glp-1 manufacturing process Impact of and Compounding on Properties and Quality of Follow-On Polypeptide Drugs | Pharmaceutical Research The GLP-1 boom: Challenges, trends,

Chest 2007;131:595607

On the other hand, GLP-1RAs can inhibit the excessively activated p38 MAPK/NF-B pathway, exerting antioxidant effects (147)

doi: 10.1016/S2213-8587(20)30313-2

doi: 10.3390/livers3020014

Clinical trials showed significant weight loss, though cardiovascular effects require careful monitoring

Combined therapy that involves the inhibition of Gln metabolism alongside PD-L1 blockade has been shown to enhance the anti-tumor immune response of T cells ( in vivo and in vitro ( DON, which exhibits high structural similarity to Gln, enhances the cytotoxic effects of CD8+ T cells while inhibiting Gln metabolism in cancer cells